Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 1
1957 4
1958 2
1960 2
1963 1
1964 1
1966 1
1967 1
1968 4
1969 4
1970 3
1971 4
1972 5
1973 3
1974 8
1975 5
1976 8
1977 5
1978 12
1979 10
1980 13
1981 11
1982 19
1983 13
1984 10
1985 13
1986 9
1987 9
1988 15
1989 6
1990 11
1991 12
1992 13
1993 23
1994 11
1995 18
1996 17
1997 16
1998 9
1999 17
2000 21
2001 14
2002 10
2003 18
2004 21
2005 20
2006 27
2007 25
2008 32
2009 25
2010 24
2011 17
2012 16
2013 32
2014 17
2015 27
2016 14
2017 22
2018 22
2019 29
2020 32
2021 35
2022 36
2023 42
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

907 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine.
Chang YS, Huang K, Lee JM, Vagts CL, Ascoli C, Amin MR, Ghassemi M, Lora CM, Edafetanure-Ibeh R, Huang Y, Cherian RA, Sarup N, Warpecha SR, Hwang S, Goel R, Turturice BA, Schott C, Hernandez M, Chen Y, Jorgensen J, Wang W, Rasic M, Novak RM, Finn PW, Perkins DL. Chang YS, et al. Among authors: novak rm. Elife. 2024 Apr 24;13:e83641. doi: 10.7554/eLife.83641. Elife. 2024. PMID: 38656290 Free PMC article.
From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide.
Sweis JJG, Alnaimat F, Esparza V, Prasad S, Azam A, Modi Z, Al-Awqati M, Jetanalin P, Sweis NJ, Ascoli C, Novak RM, Rubinstein I, Papanikolaou IC, Sweiss N. Sweis JJG, et al. Among authors: novak rm. Int J Environ Res Public Health. 2024 Mar 11;21(3):325. doi: 10.3390/ijerph21030325. Int J Environ Res Public Health. 2024. PMID: 38541324 Free PMC article. Review.
Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023.
Dahl BA, Tritter B, Butryn D, Dahlke M, Browning S, Gelting R, Fleming M, Ortiz N, Labrador J, Novak R, Fitter D, Bell E, McGuire M, Rosenbaum R, Pulwer R, Wun J, McCaffrey A, Chowdhury M, Parks N, Cunningham M, Mounts A, Curry D, Richardson D, Grant G. Dahl BA, et al. Among authors: novak r. Vaccine. 2024 Mar 23:S0264-410X(24)00359-1. doi: 10.1016/j.vaccine.2024.03.054. Online ahead of print. Vaccine. 2024. PMID: 38523004 Free article.
Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019.
Kekeisen-Chen JF, Tarbangdo FT, Sharma S, Marasini D, Marjuki H, Kibler JL, Reese HE, Ouattara S, Ake FH, Yameogo I, Ouedraogo I, Seini E, Zoma RL, Tonde I, Sanou M, Novak RT, McNamara LA. Kekeisen-Chen JF, et al. Among authors: novak rt. Emerg Infect Dis. 2024 Mar;30(3):460-468. doi: 10.3201/eid3003.221760. Emerg Infect Dis. 2024. PMID: 38407254 Free PMC article.
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, Fitch KV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C, Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B, Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Trial Writing Group. Lu MT, et al. JAMA Cardiol. 2024 Apr 1;9(4):323-334. doi: 10.1001/jamacardio.2023.5661. JAMA Cardiol. 2024. PMID: 38381407 Free PMC article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
Cardemil CV, Cao Y, Posavad CM, Badell ML, Bunge K, Mulligan MJ, Parameswaran L, Olson-Chen C, Novak RM, Brady RC, DeFranco E, Gerber JS, Pasetti M, Shriver M, Coler R, Berube B, Suthar MS, Moreno A, Gao F, Richardson BA, Beigi R, Brown E, Neuzil KM, Munoz FM; MOMI-Vax Study Group. Cardemil CV, et al. Among authors: novak rm. Pediatrics. 2024 Mar 1;153(3):e2023064252. doi: 10.1542/peds.2023-064252. Pediatrics. 2024. PMID: 38332733
907 results